The Diabetes Care Devices by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Diabetes Care Devices Market:
https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-global-market-report
According to The Business Research Company’s Diabetes Care Devices, The diabetes care devices market size has grown strongly in recent years. It will grow from $64.27 billion in 2023 to $69.46 billion in 2024 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to increasing diabetes prevalence, economic growth, public health insurance reforms, increased geriatric population, and increased healthcare expenditure.
The diabetes care devices market size is expected to see strong growth in the next few years. It will grow to $93.2 billion in 2028 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to increase in r&d investments and research collaborations, increase in disease burden, government initiatives and technological development . Major trends in the forecast period include stick free glucose testing, glucose responsive insulins (gris), artificial pancreas, shift in traditional insulin syringes, wearable and mobile glucose monitoring systems, intelligent glucose meters.
Increasing healthcare expenditures are anticipated to propel the growth of the diabetes care device market going forward. Healthcare expenditures refer to the total amount spent on healthcare-related services, products, and activities within a specified period, typically on an individual, community, national, or global level. The increasing healthcare expenditures, coupled with greater access to healthcare services and rising diabetes diagnoses, drive heightened investments in research and development, leading to the advancement of diabetes care devices such as improved glucose monitoring systems, insulin delivery devices, and digital health solutions. For instance, in May 2023, the Office for National Statistics, a UK-based statistics authority, reported that healthcare spending in the UK increased by 9.4% in nominal terms and 9.7% in real terms. UK total healthcare expenditure in 2021 was $367.25 billion (£280.7 billion), and pharmaceutical expenditure was $51.84 billion (£39.6 billion) in 2021. Further, spending on preventive care was $45.93 billion (£35.1 billion) in 2021, more than doubling from the previous year. Therefore, increasing healthcare expenditure will drive the growth of the diabetes care device market going forward.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=3609&type=smp
The diabetes care devices market covered in this report is segmented –
1) By Type: Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters
2) By Type of Expenditure: Public, Private
3) By Product: Instruments/Equipment, Disposables
4) By Type Of Testing: Point Of Care (POC) Testing, Non-Point Of Care (POC) Testing
5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users
Subsegments Covered: Glucose Dehydrogenase, Glucose Oxidase, Pens, Injectors And Pumps, Syringes
Top Major Players
Becton
Dickinson and Company
Novo Nordisk A/S
Roche Holding AG
Nipro Corporation
Major companies operating in the diabetes care devices market are focused on developing innovative products, such as Medtronic Extended Infusion, to increase the profitability in the market. The Medtronic Extended Infusion Set is a tube that delivers insulin from the pump to the body and is designed for up to 7 days of wear. For instance, in April 2021, Medtronic Plc, a US-based medical equipment manufacturer, launched the Medtronic Extended infusion set in select European countries. The product is currently accessible for purchase in specific European nations, initially debuting in Finland and Belgium, with plans for a gradual rollout to additional European countries. Moreover, the Extended infusion set incorporates innovative technology and alternative materials, enabling it to be worn for double the duration compared to other Medtronic infusion sets, which are typically approved for 2-3 days of use.
The diabetes care devices market report table of contents includes:
1. Executive Summary
2. Diabetes Care Devices Market Characteristics
3. Diabetes Care Devices Product/Service Analysis -Product/Service Examples
4. Diabetes Care Devices Market Trends And Strategies
5. Diabetes Care Devices Market – Macro Economic Scenario
……………………….
68. Global Diabetes Care Devices Market Competitive Benchmarking
69. Global Diabetes Care Devices Market Competitive Dashboard
70. Key Mergers And Acquisitions In The Diabetes Care Devices Market
71. Diabetes Care Devices Market Future Outlook and Potential Analysis
72. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
